Yes, nanotechnology offers significant potential for targeted drug delivery. Nanocarriers such as liposomes, dendrimers, and polymeric nanoparticles can be designed to deliver therapeutic agents directly to specific cellular components or tissues, minimizing systemic toxicity. For example, ligand-conjugated nanoparticles can specifically bind to receptors on cancer cells, ensuring the targeted release of anticancer drugs.
